Frazier Life Sciences Acquisition Corp. II (NASDAQ:FLSC) CEO Albert Cha Purchases 300,000 Shares of Stock

Frazier Life Sciences Acquisition Corp. II (NASDAQ:FLSC) CEO Albert Cha acquired 300,000 shares of the stock in a transaction on Thursday, October 15th. The shares were bought at an average price of $10.00 per share, for a total transaction of $3,000,000.00. Following the purchase, the chief executive officer owned 300,000 shares in the company, valued at approximately $3,000,000. This trade represents a ? increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through the SEC website.

Frazier Life Sciences Acquisition Corp. II Stock Up 1.9%

NASDAQ FLSC traded up $0.20 during midday trading on Thursday, hitting $10.49. The company had a trading volume of 84,224 shares. Frazier Life Sciences Acquisition Corp. II has a twelve month low of $10.18 and a twelve month high of $10.50.

About Frazier Life Sciences Acquisition Corp. II

Frazier Life Sciences Acquisition Corp. II is a special purpose acquisition company, or SPAC, focused on identifying and combining with a business in the life sciences sector. The company does not operate a conventional commercial business and was formed to pursue a merger, acquisition, or similar business combination.

Its target opportunities may include companies involved in biotechnology, pharmaceuticals, medical devices, diagnostics, or other healthcare-related technologies. The company’s objective is to provide a publicly traded platform for a private life sciences business through a business combination.

Frazier Life Sciences Acquisition Corp.